Less Invasive Mutation Testing
Blood-Based Genetic Insights to Guide Personalized Cancer Care
DNA GTx’s Liquid Biopsy test analyzes circulating cell-free DNA (cfDNA) from a simple blood sample to detect somatic mutations linked to cancer. This minimally invasive approach enables real-time tumor monitoring, early detection of actionable and resistance mutations, and precision-guided treatment decisions, especially when tissue samples are unavailable or insufficient.
Who is this Test for?
- Patients with advanced, recurrent, or metastatic cancer
- Individuals for whom tissue biopsy is not possible or safe
- Patients undergoing treatment who require tumor monitoring
- Those needing insights into actionable mutations for therapy selection
Variant Types Detected
Single Nucleotide Variants (SNVs)
- SNVs are single base changes between reference and the patient's genome.
Insertions and Deletions (Indels)
Insertion
Deletion
- Indels are small changes in DNA where a few bases are either added (insertion) or removed (deletion).
What it Screens for
- Genetic mutations driving solid tumors
- Lung cancer
- Colorectal cancer
- Breast cancer
Key Benefits
- Minimally-invasive Testing: Detects cancer-related mutations from a simple blood sample.
- Monitors Cancer Progress: Helps track tumor changes without needing tissue biopsies.
Turn Around Time
- 10 Days
Can it Be Done After Chemotherapy?
Yes. Liquid biopsy is well-suited for use after chemotherapy and during treatment, especially when new tissue biopsies are not feasible. It can help detect residual disease, treatment response, or emerging resistance mutations.
Do You Need a Doctor’s Request?
Yes. This test must be ordered by a licensed healthcare provider to ensure it is used appropriately and results are interpreted within the clinical context.
How it Works?
Step 1: Blood Sample Collection
- A blood draw is taken from the patient.
- The sample contains DNA that can reveal important health insights.
Step 2: cfDNA Extraction
- The cfDNA is carefully separated from the rest of the blood.
- These tiny DNA fragments can reveal genetic changes or risks.
Step 3: Library Preparation
- The DNA is prepared so it can be read by our sequencing machines.
- We add special tags and focus on the most important parts of your DNA.
Step 4: Next Generation Sequencing
- This is how we ‘’read’’ your DNA using advanced technology.
- It helps us find changes or mutations in your genes.
Step 5: Data Analysis
- Our proprietary software (D-KRYPT) helps us understand what the DNA changes mean.
- The results are derived from trusted medical databases.
Step 6: Personalized Patient Report
- You got a clear, easy-to-read report with important findings.
- Your doctor can use this to guide treatment or next steps.
Oncology Test Panels
Séquençage clinique
Solutions for Researchers
Prise en charge prénatale
Médecine régénérative
Healthcare
Agriculture
Empower Your Oncology Practice with Liquid Biopsy
Partner with us to bring fast, safe, and actionable cancer diagnostics to your patients.
*All information is handled with strict confidentiality.
A Simple Blood Test with Powerful Answers
Every cancer is unique—and so is every patient. With DNA GTx Liquid Biopsy, a single blood draw can unlock insights into your tumor’s DNA, guiding your doctor to targeted therapies that work for you.
*All information is handled with strict confidentiality.
